JS06.5.A TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL Article

Ahluwalia, MS, Khosla, AA, Ozair, A et al. (2023). JS06.5.A TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL . NEURO-ONCOLOGY, 25(Supplement_2), ii10-ii11. 10.1093/neuonc/noad137.028

cited authors

  • Ahluwalia, MS; Khosla, AA; Ozair, A; Kotecha, RR; McDermott, MW; Mehta, MP; Sandoval-Leon, AC; Mahtani, R; Peereboom, DM

authors

publication date

  • September 8, 2023

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Neurosciences
  • Orphan Drug
  • Patient Safety
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ii10

end page

  • ii11

volume

  • 25

issue

  • Supplement_2